Zealand Pharma A/S
ZLDPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $48,980,903 | $21,263,347 | $9,042,045 | $6,176,674 |
| - Cash | $480,303 | $449,311 | $1,069,234 | $1,129,103 |
| + Debt | $391,756 | $119,230 | $443,472 | $787,429 |
| Enterprise Value | $48,892,356 | $20,933,266 | $8,416,283 | $5,835,000 |
| Revenue | $62,691 | $342,788 | $103,986 | $292,567 |
| % Growth | -81.7% | 229.6% | -64.5% | – |
| Gross Profit | $54,817 | $323,614 | $73,275 | $173,753 |
| % Margin | 87.4% | 94.4% | 70.5% | 59.4% |
| EBITDA | -$1,023,551 | -$657,948 | -$665,262 | -$711,850 |
| % Margin | -1,632.7% | -191.9% | -639.8% | -243.3% |
| Net Income | -$1,078,828 | -$703,739 | -$965,610 | -$1,018,149 |
| % Margin | -1,720.9% | -205.3% | -928.6% | -348% |
| EPS Diluted | -16.24 | -12.44 | -20.9 | -23.75 |
| % Growth | -30.5% | 40.5% | 12% | – |
| Operating Cash Flow | -$930,816 | -$425,668 | -$942,209 | -$1,211,971 |
| Capital Expenditures | -$13,148 | -$23,749 | -$11,710 | -$22,133 |
| Free Cash Flow | -$943,964 | -$449,417 | -$953,919 | -$1,234,104 |